| Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non … KK Jørgensen, IC Olsen, GL Goll, M Lorentzen, N Bolstad, ... The Lancet 389 (10086), 2304-2316, 2017 | 907 | 2017 |
| Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial EA Haavardsholm, AB Aga, IC Olsen, S Lillegraven, HB Hammer, T Uhlig, ... bmj 354, 2016 | 326 | 2016 |
| Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial HO Skjerven, EM Rehbinder, R Vettukattil, M LeBlanc, B Granum, ... The Lancet 395 (10228), 951-961, 2020 | 210 | 2020 |
| Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010 AB Aga, E Lie, T Uhlig, IC Olsen, A Wierød, S Kalstad, E Rødevand, ... Annals of the rheumatic diseases 74 (2), 381-388, 2015 | 198 | 2015 |
| ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial Ø Torkildsen, S Wergeland, S Bakke, AG Beiske, KS Bjerve, H Hovdal, ... Archives of neurology 69 (8), 1044-1051, 2012 | 166 | 2012 |
| Performance development in adolescent track and field athletes according to age, sex and sport discipline E Tønnessen, IS Svendsen, IC Olsen, A Guttormsen, T Haugen PloS one 10 (6), e0129014, 2015 | 145 | 2015 |
| Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to … LB Nordberg, S Lillegraven, E Lie, AB Aga, IC Olsen, HB Hammer, T Uhlig, ... Annals of the rheumatic diseases 76 (2), 341-345, 2017 | 139 | 2017 |
| Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women—a double-blind, randomized non-inferiority trial I Vik, M Bollestad, N Grude, A Bærheim, E Damsgaard, T Neumark, ... PLoS medicine 15 (5), e1002569, 2018 | 129 | 2018 |
| Carotid plaque characteristics and disease activity in rheumatoid arthritis AG Semb, S Rollefstad, SA Provan, TK Kvien, E Stranden, IC Olsen, ... The Journal of rheumatology 40 (4), 359-368, 2013 | 124 | 2013 |
| Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study SH Sveaas, IJ Berg, SA Provan, AG Semb, KB Hagen, N Vøllestad, ... PloS one 9 (9), e108688, 2014 | 123 | 2014 |
| Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: open‐label extension of the NOR‐SWITCH trial GL Goll, KK Jørgensen, J Sexton, IC Olsen, N Bolstad, EA Haavardsholm, ... Journal of internal medicine 285 (6), 653-669, 2019 | 115 | 2019 |
| NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo … PS Sorensen, SI Mellgren, A Svenningsson, I Elovaara, JL Frederiksen, ... The Lancet Neurology 8 (6), 519-529, 2009 | 113 | 2009 |
| Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register E Lie, U Lindström, T Zverkova-Sandström, IC Olsen, H Forsblad-d'Elia, ... Annals of the rheumatic diseases 76 (9), 1515-1521, 2017 | 103 | 2017 |
| Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI … F Gandjbakhch, EA Haavardsholm, PG Conaghan, B Ejbjerg, V Foltz, ... The Journal of rheumatology 41 (2), 398-406, 2014 | 99 | 2014 |
| A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics MN Lyngbakken, JE Berdal, A Eskesen, D Kvale, IC Olsen, CS Rueegg, ... Nature communications 11 (1), 5284, 2020 | 88 | 2020 |
| Rosuvastatin‐induced carotid plaque regression in patients with inflammatory joint diseases: the ROsuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and other … S Rollefstad, E Ikdahl, J Hisdal, IC Olsen, I Holme, HB Hammer, ... Arthritis & rheumatology 67 (7), 1718-1728, 2015 | 81 | 2015 |
| The frequency of intrapartum caesarean section use with the WHO partograph versus Zhang's guideline in the Labour Progression Study (LaPS): a multicentre, cluster-randomised … S Bernitz, R Dalbye, J Zhang, TM Eggebø, KF Frøslie, IC Olsen, E Blix, ... The Lancet 393 (10169), 340-348, 2019 | 79 | 2019 |
| Predictive value of arterial stiffness and subclinical carotid atherosclerosis for cardiovascular disease in patients with rheumatoid arthritis E Ikdahl, S Rollefstad, G Wibetoe, IC Olsen, IJ Berg, J Hisdal, T Uhlig, ... The Journal of rheumatology 43 (9), 1622-1630, 2016 | 76 | 2016 |
| Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study SH Sveaas, IJ Berg, SA Provan, AG Semb, IC Olsen, T Ueland, P Aukrust, ... Scandinavian journal of rheumatology 44 (2), 118-124, 2015 | 75 | 2015 |
| Bioavailability of EPA and DHA delivered by gelled emulsions and soft gel capsules IJ Haug, LB Sagmo, D Zeiss, IC Olsen, KI Draget, T Seternes European journal of lipid science and technology 113 (2), 137-145, 2011 | 73 | 2011 |
Tore KvienProfessor, Universitetet i OsloVerified email at medisin.uio.no
